Facebook Twitter


Mobile QR Codes Hit The Wall Street Journal. Email Overload Fix: 3 Sentence Emails. Email is taking up too much time in our lives.

Email Overload Fix: 3 Sentence Emails

Do yourself and your recipients a favor by making your emails 3 sentences or less. If we all do it, imagine the time we’ll have to do other things. If this was an actual email reply and not a blog post, it would have ended before this sentence started. Dahlias make me smile. Imaging Biomarkers. About « Dispatches from the other side of the world. My name is Carol Sormilic and I’m a vice president at IBM where I am responsible for the technology that drives our workplace.

About « Dispatches from the other side of the world

I’m moving my work and my life from the United States to the “other side of the world” where I’ll be located in Shanghai, China. In this space I plan to chronicle my adventure. Disclaimer: The content here is my own and does not necessarily represent my employer’s positions, strategies or opinions. Internet Statistics & Social Media Usage. 5 Staggeringly Simple Ways to Create Custom Facebook Landing Tabs. 3Q Report VC report from OnBioVC. For those of you interested in life science VCs, M&A and IPO’s, the latest OnBioVC report is now available for download here (pdf).

3Q Report VC report from OnBioVC

Inevitably, in the current economic climate, the financial trend is a downwards one, as evidenced by the findings: “The 3Q10 OnBioVC Trend Analysis tracked, in aggregate, 70 biopharma, diagnostic, device, medical-IT and biofuel venture financings totaling $1,420.0M. 3Q Report VC report from OnBioVC. Just another WordPress site. The Cancer Plus Daily. @erohealth same here. NY Chemotherapy Foundation Symposium. This week heralds a busy one with the upcoming annual NY Chemotherapy Foundation (Greenspan) meeting that begins tomorrow at the Marriott Marquis in Times Square with the Pediatric session in the afternoon and finishes on Saturday with the Nursing session.

NY Chemotherapy Foundation Symposium

I’ll be at the Greenspan event from Weds to Fri, please do say hello if you see me around. In the meantime, I’ve been pleasantly surprised at the number of signups to the conference newsletter (see the sign up widget in the right hand margin —>). The first one, from AACR on colon cancer, goes out this on Wednesday week, please sign up before then if you would like to receive it. More newsletters will follow soon on the Greenspan Meeting, ASH and SABCS. I’ve just added a new meeting to my January conference schedule and will be attending the 6th International Society of Gastroenterological Carcinogenesis in Houston, Texas. NY Chemotherapy Foundation Symposium. RT @ericgarland: Scott Adams' fantastic suggestion to end political parties in America.

Imagine a democratic political system in which no one is allowed to be a member of a political party.

RT @ericgarland: Scott Adams' fantastic suggestion to end political parties in America

How would things be different? My hypothesis is that confirmation bias, or cognitive dissonance, or something of that nature, influences voters to irrationally agree with the platform of their own party no matter what the facts suggest. RockMelt - Your Browser. Re-imagined. Connect for an invitation. @rvidal no worries, can wait until during week. Can drag pdfs into Zotero or Papers, do refs from there. Get this. Gingerbread Cinnamon Rolls Recipe. Gingerbread Cinnamon Rolls Ingredients packages active dry yeast tablespoons vegetable oil teaspoon ground cinnamon.

Gingerbread Cinnamon Rolls Recipe

Hyde Park. Big Pharma settlements with the Department of Justice - let's look at the scorecard. From PharmaGossip, we have a full accounting of the recent settlements between the US Department of Justice and Big Pharma companies -- for some sort of fraudulent or otherwise criminal activity.

Big Pharma settlements with the Department of Justice - let's look at the scorecard

PharmaGossip: Big Pharma settlements with the DOJ - let's look at the scorecard. The score stands with the DOJ collecting $5.3 B in fines for bad behavior. Prioritizing genes associated with prostate cancer development. Our approach is based on the ideas that tumorigenesis is a continuous process and that the gene-expression signature underlying the development of bone metastases starts to form in the early stages of prostate tumorigenesis and becomes well developed in the later stages.

Prioritizing genes associated with prostate cancer development

We have assumed that combining meta-analyses of different steps of prostate carcinogenesis and assigning greater weight to more-specific data might improve identification of genes associated with prostate tumorigenesis, especially those involved in the development of bone metastases; therefore, we have up-weighted the third level of meta-analysis. First level of the meta-analysis The tendency of prostate tumor to metastasize to bone is a hallmark of prostate tumorigenesis. Breast and lung cancer also often metastasize to bone, although not as frequently as prostate cancer does. Bone-metastasizing cancers may share a gene-expression signature that predisposes them to form bone metastases. How to Export Your Facebook Friends’ E-mail Addresses. MDACC Study Summary 2008-0805. ESPN NFL I have become that Fantasy Guy. Gmail Tests Call Recording. Andrew Banchich spotted a new Gmail feature that lets you record calls.

Gmail Tests Call Recording

I don't see the call record button in my account, so it's probably an experimental feature that's not yet widely available. It's similar to the call recording feature from Google Voice. "In order to record your call, simply press 4. You can do it when you first accept a call, or any time after it's started. Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years: the prospective, multicentre Stop Imatinib (STIM) trial : The Lancet Oncology. Introduction Imatinib (Novartis, East Hanover, NJ, USA) is the standard of care for patients with chronic myeloid leukaemia (CML), and induces durable responses and prolongs event-free survival and progression-free survival.1—3 In the International Randomised Study of Interferon versus STI571 (IRIS) protocol,4, 5 the estimated overall survival of patients who received imatinib as initial therapy was 89% at 5 years and 85% at 8 years (93% when deaths only related to CML were considered).

Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years: the prospective, multicentre Stop Imatinib (STIM) trial : The Lancet Oncology

However, current practice has been for patients to continue treatment indefinitely, and the ability of imatinib to eradicate the CML clone is uncertain. Teva, Sandoz May Bypass New Pathway for Copying Biologic Drugs. Companies that copy biotechnology drugs, led by Teva Pharmaceutical Industries Ltd., will be able to bypass a new process set up by the U.S. health overhaul to get their products approved, regulators said. The Food and Drug Administration will allow generic-drug makers to use either the new system, which requires them to give proprietary data to brand-name drugmakers at the point they seek approval, or an older system used to clear novel biologics, which keeps that information private, said spokeswoman Sandy Walsh. While the FDA wasn’t expected to take an immediate stand on the process, Walsh said the new law accommodates both. 50 office-speak phrases you love to hate. Management speak - don't you just hate it?

Emphatically yes, judging by readers' responses to writer Lucy Kellaway's campaign against office jargon. Here, we list 50 of the best worst examples. 1. "When I worked for Verizon, I found the phrase going forward to be more sinister than annoying. TGIF! It's Buzzword Bingo time - who wants to play? @christianetrue. PPC Text Ad Testing for Statistical Significance. The onco-social Daily. News: Cancer Stem Cells Can’t Stand the Heat. Sometimes zapping a tumor with ionizing radiation doesn’t work out as planned.

The tumor shrinks at first, but stem cells within the tumor survive and eventually seed the growth of new, more aggressive tumors. Now researchers have shown that this extraordinary radiation-resistance among tumor stem cells can be dramatically lowered by heating them up. The results were obtained in highly aggressive mouse and human breast cancer tumors, but the technique could possibly be used against many types of cancer. The paper is the cover story in the October 27, 2010 issue of Science Translational Medicine. We hypothesized that the heat was sensitizing tumors mainly by disrupting their stem cells’ DNA-repair capacity. Tips for questioning costs in today’s health care system. By Joanna Fief About two years ago in the wee hours of the morning, I found myself in a local emergency room with severe stomach pain, incessant vomiting and dehydration.

It wasn’t pretty, and I was desperate for something – anything – to ease my pain and stop my vomiting. Gratefully, within minutes of receiving an IV with medications for pain and nausea, my symptoms subsided. After a couple of blood tests that all came back normal, I was discharged. The ER doctor said I probably just had a virus. MannKind Accused of Data Fraud Coverup. (Updated throughout with with more information, including comments from MannKind management and new stock price.) VALENCIA, Calif. (TheStreet) -- A MannKind (MNKD_) senior manager says he uncovered potentially serious problems with clinical trials of the company's Afrezza inhaled insulin device and accuses the company of willingly keeping the information from U.S. regulators, according to a wrongful termination lawsuit filed in September.

The MannKind senior manager, John Arditi, who filed the lawsuit against the company in New Jersey Superior Court, claims he was wrongfully fired by MannKind after internal audits he conducted in November 2009 uncovered "potential fraud and scientific misconduct" involving Afrezza clinical trial data, according to a copy of the lawsuit obtained by TheStreet. Arditi, in his lawsuit, says he urged his superiors at MannKind to report his findings to the U.S. My Passionate Encounter in Shanghai and a Few of my Other Experiences. Where Drugs Come From: The Numbers. Brentuximab Vedotin (SGN-35) for Relapsed CD30-Positive Lymphomas. Brentuximab Vedotin (SGN-35) for Relapsed CD30-Positive Lymphomas. Money for Science May Be Scarce With New Congress. Making Sure the NIH (and Innovation) Didn’t Lose in Tuesday’s Election.